Targeting diseased tissues by pHLIP insertion at low cell surface pH

Frontiers in Physiology

Volumn 5 MAR, Issue , 2014, Pages

  Andreev, Oleg A ^a   Engelman, Donald M ^b   Reshetnyak, Yana K ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Drug delivery; Imaging; Nanotechnology; Universal health test

Indexed keywords

AMANITIN; CARRIER PROTEIN; CELL PENETRATING PEPTIDE; GOLD NANOPARTICLE; GRAMICIDIN; LIPOSOME; MEMBRANE PROTEIN; NANOCARRIER; NANOPARTICLE; PH LOW INSERTION PEPTIDE; PHALLOIDIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIPROLIFERATIVE ACTIVITY; CANCER CELL; CELL MEMBRANE PERMEABILITY; CELL PH; CELL SURFACE; CONJUGATION; CROSS LINKING; DRUG TARGETING; ENDOCYTOSIS; HYDROPHOBICITY; LIPID BILAYER; MEMBRANE BINDING; MEMBRANE FUSION; MEMBRANE TRANSPORT; NONHUMAN; PANCREAS TUMOR; REVIEW; SURFACE CHARGE;

EID: 84897930823     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00097     Document Type: Review

References (52)

1. An, M., Wijesinghe, D., Andreev, O. A., Reshetnyak, Y. K., and Engelman, D. M. (2010). pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 107, 20246-20250. doi: 10.1073/pnas.1014403107.
2. Andreev, O. A., Dupuy, A. D., Segala, M., Sandugu, S., Serra, D. A., Chichester, C. O., et al. (2007). Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc. Natl. Acad. Sci. U.S.A. 104, 7893-7898. doi: 10.1073/pnas.0702439104.
3. Andreev, O. A., Engelman, D. M., and Reshetnyak, Y. K. (2009). Targeting acidic diseased tissue: new technology based on use of the pH (Low) Insertion Peptide (pHLIP). Chim. Oggi 27, 34-37.
4. Andreev, O. A., Engelman, D. M., and Reshetnyak, Y. K. (2010a). pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents. Mol. Membr. Biol. 27, 341-352. doi: 10.3109/09687688.2010.509285.
5. Andreev, O. A., Karabadzhak, A. G., Weerakkody, D., Andreev, G. O., Engelman, D. M., and Reshetnyak, Y. K. (2010b). pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path. Proc. Natl. Acad. Sci. U.S.A. 107, 4081-4086. doi: 10.1073/pnas.0914330107.
6. Barrera, F. N., Weerakkody, D., Anderson, M., Andreev, O. A., Reshetnyak, Y. K., and Engelman, D. M. (2011). Roles of carboxyl groups in the transmembrane insertion of peptides. J. Mol. Biol. 413, 359-371. doi: 10.1016/j.jmb.2011.08.010.
7. Bechara, C., and Sagan, S. (2013). Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett. 587, 1693-1702. doi: 10.1016/j.febslet.2013.04.031.
8. Carrigan, C. N., and Imperiali, B. (2005). The engineering of membrane-permeable peptides. Anal. Biochem. 341, 290-298. doi: 10.1016/j.ab.2005.03.026.
9. Chan, D. I., Prenner, E. J., and Vogel, H. J. (2006). Tryptophan-and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta 1758, 1184-1202. doi: 10.1016/j.bbamem.2006.04.006.
10. Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R., and Tsourkas, A. (2012). Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338, 903-910. doi: 10.1126/science.1226338.
11. Chiche, J., Brahimi-Horn, M. C., and Pouyssegur, J. (2010). Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J. Cell. Mol. Med. 14, 771-794. doi: 10.1111/j.1582-4934.2009.00994.x.
12. Daumar, P., Wanger-Baumann, C. A., Pillarsetty, N., Fabrizio, L., Carlin, S. D., Andreev, O. A., et al. (2012). Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation. Bioconjug. Chem. 23, 1557-1566. doi: 10.1021/bc3000222.
13. Davies, A., Lewis, D. J., Watson, S. P., Thomas, S. G., and Pikramenou, Z. (2012). pH-controlled delivery of luminescent europium coated nanoparticles into platelets. Proc. Natl. Acad. Sci. U.S.A. 109, 1862-1867. doi: 10.1073/pnas.1112132109.
14. Davis, M. E., Chen, Z. G., and Shin, D. M. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7, 771-782. doi: 10.1038/nrd2614.
15. Ferrari, M. (2005). Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5, 161-171. doi: 10.1038/nrc1566.
16. Gatenby, R. A., and Gillies, R. J. (2007). Glycolysis in cancer: a potential target for therapy. Int. J. Biochem. Cell Biol. 39, 1358-1366. doi: 10.1016/j.biocel.2007.03.021.
17. Gerweck, L. E., and Seetharaman, K. (1996). Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 56, 1194-1198.
18. Gillies, R. J., Verduzco, D., and Gatenby, R. A. (2012). Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat. Rev. Cancer 12, 487-493. doi: 10.1038/nrc3298.
19. Gindy, M. E., and Prud'homme, R. K. (2009). Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin. Drug Deliv. 6, 865-878. doi: 10.1517/17425240902932908.
20. Guo, L., and Gai, F. (2010). Heterogeneous diffusion of a membrane-bound pHLIP peptide. Biophys. J. 98, 2914-2922. doi: 10.1016/j.bpj.2010.03.050.
21. Han, L., Ma, H., Guo, Y., Kuang, Y., He, X., and Jiang, C. (2013). pH-controlled delivery of nanoparticles into tumor cells. Adv. Healthc. Mater. 2, 1435-1439. doi: 10.1002/adhm.201300013.
22. Harris, T. K., and Turner, G. J. (2002). Structural basis of perturbed pKa values of catalytic groups in enzyme active sites. IUBMB Life 53, 85-98. doi: 10.1080/15216540211468.
23. Hashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V., and Gillies, R. J. (2011). Imaging pH and metastasis. NMR Biomed. 24, 582-591. doi: 10.1002/nbm.1644.
24. Hunt, J. F., Earnest, T. N., Bousche, O., Kalghatgi, K., Reilly, K., Horvath, C., et al. (1997). A biophysical study of integral membrane protein folding. Biochemistry 36, 15156-15176. doi: 10.1021/bi970146j.
25. Karabadzhak, A. G., Weerakkody, D., Wijesinghe, D., Thakur, M. S., Engelman, D. M., Andreev, O. A., et al. (2012). Modulation of the pHLIP transmembrane helix insertion pathway. Biophys. J. 102, 1846-1855. doi: 10.1016/j.bpj.2012.03.021.
26. Li, N., Yin, L., Thevenin, D., Yamada, Y., Limmon, G., Chen, J., et al. (2013). Peptide targeting and imaging of damaged lung tissue in influenza-infected mice. Future Microbiol. 8, 257-269. doi: 10.2217/fmb.12.134.
27. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3-26. doi: 10.1016/S0169-409X(00)00129-0.
28. Loja, M. N., Luo, Z., Greg Farwell, D., Luu, Q. C., Donald, P. J., Amott, D., et al. (2013). Optical molecular imaging detects changes in extracellular pH with the development of head and neck cancer. Int. J. Cancer 132, 1613-1623. doi: 10.1002/ijc.27837.
29. Macholl, S., Morrison, M. S., Iveson, P., Arbo, B. E., Andreev, O. A., Reshetnyak, Y. K., et al. (2012). In vivo pH imaging with (99m)Tc-pHLIP. Mol. Imaging Biol. 14, 725-734. doi: 10.1007/s11307-012-0549-z.
30. Magdalan, J., Ostrowska, A., Piotrowska, A., Izykowska, I., Nowak, M., Gomulkiewicz, A., et al. (2010). alpha-Amanitin induced apoptosis in primary cultured dog hepatocytes. Folia Histochem. Cytobiol. 48, 58-62. doi: 10.2478/v10042-010-0010-6.
31. Moldenhauer, G., Salnikov, A. V., Luttgau, S., Herr, I., Anderl, J., and Faulstich, H. (2012). Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma. J. Natl. Cancer Inst. 104, 622-634. doi: 10.1093/jnci/djs140.
32. Moshnikova, A., Moshnikova, V., Andreev, O. A., and Reshetnyak, Y. K. (2013). Antiproliferative effect of pHLIP-amanitin. Biochemistry 52, 1171-1178. doi: 10.1021/bi301647y.
33. Musial-Siwek, M., Karabadzhak, A., Andreev, O. A., Reshetnyak, Y. K., and Engelman, D. M. (2010). Tuning the insertion properties of pHLIP. Biochim. Biophys. Acta 1798, 1041-1046. doi: 10.1016/j.bbamem.2009.08.023.
34. Osborne, A. R., Rapoport, T. A., and Van Den Berg, B. (2005). Protein translocation by the Sec61/SecY channel. Annu. Rev. Cell Dev. Biol. 21, 529-550. doi: 10.1146/annurev.cellbio.21.012704.133214.
35. Raghunand, N., Altbach, M. I., Van Sluis, R., Baggett, B., Taylor, C. W., Bhujwalla, Z. M., et al. (1999). Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochem. Pharmacol. 57, 309-312. doi: 10.1016/S0006-2952(98)00306-2.
36. Reshetnyak, Y. K., Andreev, O. A., Lehnert, U., and Engelman, D. M. (2006). Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. Proc. Natl. Acad. Sci. U.S.A. 103, 6460-6465. doi: 10.1073/pnas.0601463103.
37. Reshetnyak, Y. K., Andreev, O. A., Segala, M., Markin, V. S., and Engelman, D. M. (2008). Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc. Natl. Acad. Sci. U.S.A. 105, 15340-15345. doi: 10.1073/pnas.0804746105.
38. Reshetnyak, Y. K., Segala, M., Andreev, O. A., and Engelman, D. M. (2007). A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers. Biophys. J. 93, 2363-2372. doi: 10.1529/biophysj.107.109967.
39. Reshetnyak, Y. K., Yao, L., Zheng, S., Kuznetsov, S., Engelman, D. M., and Andreev, O. A. (2011). Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP. Mol. Imaging Biol. 13, 1146-1156. doi: 10.1007/s11307-010-0457-z.
40. Santi, L., Maggioli, C., Mastroroberto, M., Tufoni, M., Napoli, L., and Caraceni, P. (2012). Acute liver failure caused by amanita phalloides poisoning. Int. J. Hepatol. 2012, 487480. doi: 10.1155/2012/487480.
41. Segala, J., Engelman, D. M., Reshetnyak, Y. K., and Andreev, O. A. (2009). Accurate analysis of tumor margins using a fluorescent ph low insertion peptide (pHLIP). Int. J. Mol. Sci. 10, 3478-3487. doi: 10.3390/ijms10083478.
42. Sosunov, E. A., Anyukhovsky, E. P., Sosunov, A. A., Moshnikova, A., Wijesinghe, D., Engelman, D. M., et al. (2013). pH (low) insertion peptide (pHLIP) targets ischemic myocardium. Proc. Natl. Acad. Sci. U.S.A. 110, 82-86. doi: 10.1073/pnas.1220038110.
43. Takayama, K., Nakase, I., Michiue, H., Takeuchi, T., Tomizawa, K., Matsui, H., et al. (2009). Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas). J. Control. Release 138, 128-133. doi: 10.1016/j.jconrel.2009.05.019.
44. Thevenin, D., An, M., and Engelman, D. M. (2009). pHLIP-mediated translocation of membrane-impermeable molecules into cells. Chem. Biol. 16, 754-762. doi: 10.1016/j.chembiol.2009.06.006.
45. Van Den Berg, B., Clemons, W. M. Jr., Collinson, I., Modis, Y., Hartmann, E., Harrison, S. C., et al. (2004). X-ray structure of a protein-conducting channel. Nature 427, 36-44. doi: 10.1038/nature02218.
46. Vavere, A. L., Biddlecombe, G. B., Spees, W. M., Garbow, J. R., Wijesinghe, D., Andreev, O. A., et al. (2009). A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res. 69, 4510-4516. doi: 10.1158/0008-5472.CAN-08-3781.
47. Weerakkody, D., Moshnikova, A., Thakur, M. S., Moshnikova, V., Daniels, J., Engelman, D. M., et al. (2013). Family of pH (low) insertion peptides for tumor targeting. Proc. Natl. Acad. Sci. U.S.A. 110, 5834-5839. doi: 10.1073/pnas.1303708110.
48. White, S. H., and Von Heijne, G. (2004). The machinery of membrane protein assembly. Curr. Opin. Struct. Biol. 14, 397-404. doi: 10.1016/j.sbi.2004.07.003.
49. Wijesinghe, D., Arachchige, M. C., Lu, A., Reshetnyak, Y. K., and Andreev, O. A. (2013). pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis. Sci. Rep. 3:3560. doi: 10.1038/srep03560.
50. Wijesinghe, D., Engelman, D. M., Andreev, O. A., and Reshetnyak, Y. K. (2011). Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide. Biochemistry 50, 10215-10222. doi: 10.1021/bi2009773.
51. Yao, L., Daniels, J., Moshnikova, A., Kuznetsov, S., Ahmed, A., Engelman, D. M., et al. (2013a). pHLIP peptide targets nanogold particles to tumors. Proc. Natl. Acad. Sci. U.S.A. 110, 465-470. doi: 10.1073/pnas.1219665110.
52. Yao, L., Daniels, J., Wijesinghe, D., Andreev, O. A., and Reshetnyak, Y. K. (2013b). pHLIP(R)-mediated delivery of PEGylated liposomes to cancer cells. J. Control. Release 167, 228-237. doi: 10.1016/j.jconrel.2013.01.037.